| Primary |
| Acne |
45.8% |
| Product Used For Unknown Indication |
25.3% |
| Rosacea |
6.3% |
| Rheumatoid Arthritis |
5.5% |
| Granuloma Annulare |
2.8% |
| Borrelia Infection |
1.6% |
| Cholangitis Sclerosing |
1.6% |
| Renal Cyst |
1.6% |
| Parkinson's Disease |
1.2% |
| Postoperative Wound Infection |
1.2% |
| Aspergillosis |
0.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
0.8% |
| Hypothyroidism |
0.8% |
| Infection |
0.8% |
| Lyme Disease |
0.8% |
| Lymphomatoid Papulosis |
0.8% |
| Pleurodesis |
0.8% |
| Prophylaxis |
0.8% |
| Acne Pustular |
0.4% |
| Autoimmune Disorder |
0.4% |
|
| Polyarteritis Nodosa |
26.5% |
| Weight Decreased |
9.8% |
| Skin Discolouration |
6.1% |
| Rash |
5.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.5% |
| Acute Febrile Neutrophilic Dermatosis |
3.8% |
| Benign Intracranial Hypertension |
3.8% |
| Pigmentation Disorder |
3.8% |
| Serum Sickness-like Reaction |
3.8% |
| Vasculitis |
3.8% |
| Vomiting |
3.8% |
| Bone Hyperpigmentation |
3.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.0% |
| Nausea |
3.0% |
| Thyroid Disorder |
3.0% |
| Type 2 Lepra Reaction |
3.0% |
| Visual Field Defect |
3.0% |
| Arteritis |
2.3% |
| Autoimmune Hepatitis |
2.3% |
| Drug Hypersensitivity |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
27.2% |
| Drug Use For Unknown Indication |
10.9% |
| Cutaneous Sarcoidosis |
8.2% |
| Acne |
6.2% |
| Abdominal Pain |
4.7% |
| Prophylaxis |
3.9% |
| Leprosy |
3.5% |
| Anxiety |
3.1% |
| Mycobacterium Abscessus Infection |
3.1% |
| Pseudomonas Infection |
3.1% |
| Staphylococcal Sepsis |
3.1% |
| Urethritis |
3.1% |
| Urinary Tract Infection |
3.1% |
| Granuloma Annulare |
2.7% |
| Deep Vein Thrombosis |
2.3% |
| Depression |
2.3% |
| H1n1 Influenza |
2.3% |
| Influenza |
2.3% |
| Pneumonia |
2.3% |
| Septic Embolus |
2.3% |
|
| Vomiting |
14.0% |
| Swollen Tongue |
11.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.7% |
| Liver Function Test Abnormal |
4.7% |
| Rash |
4.7% |
| Rhabdomyolysis |
4.7% |
| Staphylococcal Infection |
4.7% |
| Subcutaneous Abscess |
4.7% |
| Tachycardia |
4.7% |
| Thrombocytopenia |
4.7% |
| Tooth Injury |
4.7% |
| Treatment Failure |
4.7% |
| Vanishing Bile Duct Syndrome |
4.7% |
| Weight Decreased |
4.7% |
| Xerosis |
4.7% |
| Accidental Overdose |
2.3% |
| Acute Hepatic Failure |
2.3% |
| Drug Ineffective |
2.3% |
| Drug-induced Liver Injury |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.1% |
| Acne |
10.7% |
| Prophylaxis |
7.2% |
| Pain |
4.8% |
| Head And Neck Cancer |
4.0% |
| Aplastic Anaemia |
3.8% |
| Non-small Cell Lung Cancer |
3.7% |
| Rheumatoid Arthritis |
3.5% |
| Contraception |
3.2% |
| Nausea |
3.2% |
| Rash |
3.1% |
| Depression |
2.9% |
| Hypertension |
2.7% |
| Drug Use For Unknown Indication |
2.6% |
| Constipation |
2.2% |
| Fatigue |
2.2% |
| Anxiety |
1.9% |
| Infection Prophylaxis |
1.9% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypothyroidism |
1.6% |
|
| Pulmonary Embolism |
11.3% |
| Drug Ineffective |
7.5% |
| Nausea |
7.5% |
| Vomiting |
7.5% |
| Deep Vein Thrombosis |
6.6% |
| Pain |
6.6% |
| Rash |
6.6% |
| Weight Decreased |
5.2% |
| Tachycardia |
4.7% |
| Respiratory Failure |
4.2% |
| Suicidal Ideation |
4.2% |
| Thrombosis |
3.8% |
| Weight Increased |
3.8% |
| Death |
3.3% |
| Pyrexia |
3.3% |
| Pain In Extremity |
2.8% |
| Pneumonia |
2.8% |
| Renal Failure Acute |
2.8% |
| Septic Shock |
2.8% |
| Somnolence |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
46.7% |
| Cervix Carcinoma |
13.3% |
| Convulsion |
13.3% |
| Hypothyroidism |
13.3% |
| Post-traumatic Epilepsy |
13.3% |
|
|
